首页 | 本学科首页   官方微博 | 高级检索  
     

立体定向放射治疗脑转移瘤疗效分析
引用本文:郭阳,姜炜,张文学. 立体定向放射治疗脑转移瘤疗效分析[J]. 国际放射医学核医学杂志, 2007, 31(2): 122-124
作者姓名:郭阳  姜炜  张文学
作者单位:300060 天津, 天津市环湖医院放疗科
摘    要:目的 分析立体定向放射疗法(SRT)治疗脑转移瘤的临床疗效。方法 回顾性分析66例脑转移瘤全脑放射治疗(WBRT)追加SRT和26例脑转移瘤单纯SRT的结果,分析两者在Karnofsky评分、颅内肿瘤复发率、一年生存率等方面的状况。结果 WBRT+SRT组在颅内肿瘤复发率(13.3%和42.2%)、中位复发时间(10.5个月和4.2个月)、中位生存期(13.0个月和6.5个月)与单纯SRT组相比有显著性差异(P<0.05),但在Karnofsky评分、治疗有效率、一年生存率、死亡率的差异均无统计学意义。结论 WBRT+SRT能明显改善患者的生存质量,降低肿瘤颅内复发率,是脑转移瘤的一种理想局部治疗手段。

关 键 词:脑转移瘤   立体定向放射治疗   全脑放射治疗
文章编号:1673-4114(2007)02-0122-03
收稿时间:2006-12-05
修稿时间:2006-12-05

Analysis of stereotatic radiotherapy for brain metastases
GUO Yang,JIANG Wei,ZHANG Wen-xue. Analysis of stereotatic radiotherapy for brain metastases[J]. International Journal of Radiation Medicine and Nuclear Medicine, 2007, 31(2): 122-124
Authors:GUO Yang  JIANG Wei  ZHANG Wen-xue
Affiliation:Department of Radiotherapy, Tianjin Huanhu Hospital, Tianjin 300060, China
Abstract:Objective To investigate the effect of stereotatic radiotherapy (SRT) for brain metastases.Methods Retrospect compare 66 patients treated by SRT with whole brain radiotherapy(WBRT+ SRT) to 26 patients treated by SRT alone. Results The patients treated by WBRT+ SRT had significantly benefit in lesions recurrence (13.3% vs 42.2%), middle recurrence time (10.5 months vs 4.2 months) and middle survival time(13 months vs 6.5 months) over the patients treated by SRT, respectively(P<0.05). But there are no different in terms of improving of Karnofsky score, effective rate, one-year survival rate, one-year death rate between the two groups. Conclusion WBRT+ SRT play an important role in treating brain metastases, by improving patients' life quantity and reducing recurrence.
Keywords:Brain metastases   Stereotatic radiotherapy   Whole brain radiotherapy
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《国际放射医学核医学杂志》浏览原始摘要信息
点击此处可从《国际放射医学核医学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号